Biomimetic nanoparticles for metastatic breast cancer: Advancing targeted drug delivery beyond conventional nanomedicine

Critical Reviews in Oncology/Hematology · Published 2026-07-20 · DOI 10.1016/j.critrevonc.2026.105495

Authors (6)

Urushi Rehman, Tenzin Sonam Dongsar, Tenzin Tsering Dongsar, Nazeer Hasan, Farhan Jalees Ahmed, Prashant Kesharwani

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Rehman, U., Dongsar, T., Dongsar, T., et al. (2026). Biomimetic nanoparticles for metastatic breast cancer: Advancing targeted drug delivery beyond conventional nanomedicine. Critical Reviews in Oncology/Hematology. https://doi.org/10.1016/j.critrevonc.2026.105495

Related articles

• TROP-2 in solid tumors: From oncogenic driver to therapeutic target with antibody-drug conjugates · Critical Reviews in Oncology/Hematology · 2026 · Same journal
• Circulating tumour DNA and molecular residual disease in oesophageal cancer: Clinical readiness, evidence gaps and trial-ready applications · Critical Reviews in Oncology/Hematology · 2026 · Same journal
• Molecular mechanisms of targeted therapy in breast cancer: An integrated signaling network perspective · Critical Reviews in Oncology/Hematology · 2026 · Same journal
• The adipose microenvironment in colorectal cancer: Navigating the nexus of inflammation, metabolism, and metastatic reprogramming · Critical Reviews in Oncology/Hematology · 2026 · Same journal
• Remodeling the immune microenvironment: Engineering IL-2 variants to overcome clinical bottlenecks in PD-1 inhibitor plus chemotherapy · Critical Reviews in Oncology/Hematology · 2026 · Same journal
• Extracellular vesicle-mediated immunity-coagulation interaction in cancer-associated thrombosis during the immunotherapy era · Critical Reviews in Oncology/Hematology · 2026 · Same journal
• Revisiting Diffuse Gliomas in the Era of Precision Medicine: Molecular Insights and Therapeutic Implications · Critical Reviews in Oncology/Hematology · 2026 · Same journal
• Liquid biopsy for early cancer detection in hereditary cancer syndromes: Current evidence · Critical Reviews in Oncology/Hematology · 2026 · Same journal
• Current status and prospects of chemotherapy-free strategies in ovarian cancer · Critical Reviews in Oncology/Hematology · 2026 · Same journal
• Advances in the mechanisms of exosome-derived non-coding RNAs regulating T-cell infiltration in tumors · Critical Reviews in Oncology/Hematology · 2026 · Same journal